doubled

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Source Node:
Time Stamp: April 15, 2024 1:26 PM - Modified On: April 15, 2024 - Published By:
Source Cluster:
Republished By Plato

  Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology New York, March 12, 2024 - (Plato Data) - Benzinga has published a new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring the company's groundbreaking approach to peripheral nervous system (PNS) disorders. The Benzinga article delves into the critical role of the PNS in human health and highlights how Autonomix Medical is pioneering with its catheter-based microchip sensing array technology. The article provides a comprehensive look at how Autonomix Medical is redefining treatment protocols for nerve-related

GenTwo Continues Growth Story- New Inflows of Over USD 1 bn

Source Node:
Time Stamp: February 1, 2023 2:02 AM - Modified On: February 1, 2023 - Published By:
Source Cluster:
Republished By Plato

Zurich, 1 February 2023 – _The international securitization specialist GenTwo celebrates its 5th anniversary and looks back on a fast-paced development. In 2022 the number of new products increased by 60% and international business doubled. The business momentum of GenTwo and its subsidiary GenTwo Digital has progressively picked up since the company was founded 5 years ago in February 2018. The products issued on its platform recorded over USD 1 billion in new inflows, resulting in a surge in assets under services growth to USD 2.5 billion as of today,